首页 › 重度抑郁症 › 宾夕法尼亚州 › Philadelphia
Philadelphia PA 重度抑郁症临床试验
23项针对 重度抑郁症的研究正在 Philadelphia及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
招募中3 期
- Adams Clinical Philadelphia, Philadelphia
- Flourish Research Philadelphia, Philadelphia
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
招募中3 期
- Adams Clinical Philadelphia, Philadelphia
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
招募中3 期
- Penn Medicine: University of Pennsylvania Health System, Philadelphia
- Suburban Research Associates, West Chester · 距离 24 英里
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
招募中3 期
- Adams Clinical Philadelphia, Philadelphia
- Penn Medicine: University of Pennsylvania Health System, Philadelphia
- Suburban Research Associates, West Chester · 距离 24 英里
Precision Depression Adalimumab Trial
招募中2 期
- University of Pennsylvania, Philadelphia
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
招募中3 期
- University of Pennsylvania - Perelman School of Medicine, Philadelphia
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
招募中3 期
- University of Pennsylvania, Philadelphia
Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine
招募中早期 I 期
- University of Pennsylvania, Philadelphia
Decoding and Modulating Affective Brain States
招募中注明向参与者支付报酬
- University of Pennsylvania, Philadelphia
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
招募中2 期
- Draig Clinical Site, Media · 距离 12 英里
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
招募中
- Pennsylvania Hospital, Philadelphia
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
招募中2 期
- Draig Clinical Site, Media · 距离 12 英里
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
招募中3 期
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Philadelphia
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
招募中3 期
- Adams Clinical - Philadelphia, Philadelphia
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
招募中2 期
- Adams Clinical, Philadelphia
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Philadelphia
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Philadelphia
Triage Survey for Psychiatry Research Eligibility
招募中观察性研究
- Adams Clinical, Philadelphia, Philadelphia
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
招募中2 期
- University of Pennsylvania, Philadelphia
Taking Action for College Students
招募中
- Temple University, Philadelphia
Neurofeedback to Treat Depression - 2
招募中
- Center for Neuromodulation in Depression and Stress, Philadelphia
Study of ALTO-300 in MDD
招募中2 期
- Site 350, Media · 距离 12 英里
其他城市的 重度抑郁症试验
- New York City, NY36 项研究
- Boston, MA31 项研究
- Atlanta, GA25 项研究
- Orlando, FL19 项研究
- Miami, FL18 项研究
- Chicago, IL17 项研究
- Tampa, FL17 项研究
- Houston, TX16 项研究
- San Diego, CA16 项研究
- Little Rock, AR14 项研究
- Austin, TX13 项研究
- Las Vegas, NV13 项研究
Philadelphia的其他研究
- 癌症（所有类型）59 项研究
- 乳腺癌56 项研究
- 非小细胞肺癌51 项研究
- 转移性癌症46 项研究
- 前列腺癌44 项研究
- 结直肠癌44 项研究
- 卵巢癌44 项研究
- 肺癌36 项研究
- 急性髓系白血病34 项研究
- 心力衰竭31 项研究
- 子宫内膜癌28 项研究
- 抑郁症26 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。